Study finds microdosing LSD leads to longer sleep: Insights from a controlled trial

A phase I trial to assess the effect of micro-dosing of lysergic acid diethylamide (LSD) on the sleep.

Merck’s Keytruda sales eclipse $18B on the year, while numbers for Lagevrio surprise

Merck’s blockbuster cancer drug Keytruda made $18.4 billion in the first nine months of the year — nearly the same amount as the reported revenue

October 27, 2023

The state of the union is … busy

President Joe Biden is working to lay out his health agenda for a second term, even as Congress races to finish its overdue spending bills

March 7, 2024

Extending FDA-approved cancer drug indications requires high patient numbers, study finds

Number of patient participants needed for secondary approval of a new cancer drug.

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.